Atlas Trials

Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines

Clinical trial NCT02563678 · UNKNOWN

Trial details

NCT number
NCT02563678
Sponsor
Intermountain Health Care, Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Infection
Start date
2015-04-01
Primary completion
2023-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.